Monday, May 16, 2016

Buy Granules on declines

Company Background :

Granules India Limited is a pharmaceutical company. The Company manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs). The Company's APIs portfolio includes Paracetamol, Losartan, Ibuprofen, Cetirizine, Metformin HCl, Levocitirizine, 

Methocarbamol, Rifaximin and Abacavir. Its PFIs comprise single actives, such as Ibuprofen, Guaifenesin, Methocarbamol and Ciprofloxacin, and multiple actives, such as Paracetamol and Caffeine, Paracetamol and Diphenhydramine, Paracetamol and Chlorpheniramine Maleate, and Ibuprofen and Pseudoephedrine HCl. 

Its FDs include single actives, such as Paracetamol, Guaifenesin, Metformin HCI and Naproxen Sodium, and multiple actives, such as Paracetamol and Guaifenesin; Paracetamol, Codeine Phosphate and Guaifenesin; Ibuprofen and Methocarbamol; Ibuprofen and Pseudoephedrine HCI; Ibuprofen, Pseudoephedrine HCI and Chlorpheniramine Maleate, and Paracetamol and Diphenhydramine HCl.

Stock Performance :

During the last  1 month the scrip has peaked at Rs.138 from a low of Rs.125 giving decent returns.  Three months movement is also bullish from a low of Rs.105 it has gained as much as Rs.30.  During the last 6 months it has gained.  It started upward journey from Rs.66 on Feb 11, 2016 and has touched 162 and currently declined to Rs.131.  This gives an opportunity to buy on declines ..

Our Recommendation :

Both long term and short term indicators are bullish.  Buy on declines around Rs.125 levels and hold for a target of Rs.150 in coming 6-9 months time frame.


Smart Investor - 
Equity Research

No.24 Pattamal Plaza
3rd Cross Kammanahalli

Mobile / Whatsapp -08105-737-966